Category: Consumer goods
Quick infos Headquarters: South San Francisco, California, United States Trade prices Volume: Market Cap: 1.51B Prev closed: Open: 46.45 High: 46.93 Low: 45.01 52 week low: 28.82 52 week high: 86.03 Dividends: No Dividends Next ER: November 7, 2022
Earnings History Date EPS / Forecast Revenue / Forecast February 28, 2023 November 2, 2022 -0.12 / -0.2575.59M / 66.44MBeat! August 2, 2022 -0.13 / -0.222972.9M / 68.08MBeat! May 3, 2022 -0.2 / -0.231867.78M / 61.92MBeat! February 28, 2022 -0.15 / -0.160667.34M / 62.52MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Aug 2, 2022 26.64 25.56 26.84
25.34
665.13K 3.18% Aug 1, 2022 25.82 25.74 26.65
25.46
910.48K -1.97% Jul 29, 2022 26.34 26.92 27.13
26.21
896.89K -4.08% Jul 28, 2022 27.46 26.36 27.56
25.47
834.54K 4.73% Jul 27, 2022 26.22 25.00 26.48
24.45
768.65K 6.03% Jul 26, 2022 24.73 24.53 25.50
24.10
704.65K 0.24% Jul 25, 2022 24.67 24.47 24.80
23.68
1.00M 0.53% Jul 22, 2022 24.54 26.87 26.87
24.44
967.26K -7.74% Jul 21, 2022 26.60 26.85 27.32
26.08
970.11K -1.19% Jul 20, 2022 26.92 26.06 28.13
26.03
1.02M 4.26% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2006 Employees:270 News
Veracyte GAAP EPS of -$0.12, revenue of $75.6M; raises FY outlook seekingalpha.com Nov 3, 2022 4:30 am
Veracyte (VCYT) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com Nov 2, 2022 6:55 pm Veracyte Q3 2022 Earnings Preview seekingalpha.com Nov 2, 2022 5:35 am
Veracyte Announces Three Abstracts to Be Presented at SITC 2022 Annual Meeting finance.yahoo.com Nov 1, 2022 5:11 pm
New Data Suggest Decipher GRID-Derived Genomic Signature Can Help Identify Men with Prostate Cancer Who Should Receive High-Dose Radiotherapy finance.yahoo.com Oct 25, 2022 8:30 am
Veracyte Announces New Data to be Presented at ASCO 2022 Showing Immunoscore IC Assays Ability to Identify Patients with NSCLC Who May Benefit from Immune Checkpoint Inhibitors finance.yahoo.com Oct 20, 2022 5:05 pm
New Clinical Utility Data Confirm Veracytes Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis finance.yahoo.com Oct 20, 2022 4:41 pm
Veracyte Announces Third Quarter 2021 Financial Results finance.yahoo.com Oct 20, 2022 4:05 pm After Naming a New CFO, Is This Genetic Diagnostics Company a Buy? fool.com Oct 20, 2022 6:55 am Veracyte GAAP EPS of -$0.13 beats by $0.10, revenue of $72.86M beats by $4.78M seekingalpha.com Aug 3, 2022 4:18 am Veracyte Q2 2022 Earnings Preview seekingalpha.com Aug 2, 2022 5:35 am 3 Reasons to Buy This Sizzling Growth Stock fool.com Jul 22, 2022 11:23 am Veracyte Percepta Genomic Sequencing Classifier demonstrates accuracy in lung cancer risk seekingalpha.com Jul 14, 2022 5:43 am
Veracyte Announces First Quarter 2022 Financial Results finance.yahoo.com Oct 20, 2022 4:05 pm
Veracyte Announces Second Quarter 2022 Financial Results finance.yahoo.com Oct 20, 2022 4:05 pm
Intellia Therapeutics Names Muna Bhanji, R.Ph., to its Board of Directors finance.yahoo.com Oct 20, 2022 4:01 pm
Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion finance.yahoo.com Oct 20, 2022 8:30 am
New Data Suggest Veracytes Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer finance.yahoo.com Oct 20, 2022 8:30 am
Veracyte Appoints Annie McGuire as General Counsel finance.yahoo.com Oct 20, 2022 8:30 am
Veracyte Announces that Data for Its Genomic and Immuno-Oncology Offerings Will Be Highlighted at the 2022 ASCO Annual Meeting finance.yahoo.com Oct 20, 2022 8:30 am This company doesn't provide a dividend.
Talk about Veracyte Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis